“The anti-popular directions of the EU which ensure in every possible way the profitability of the European pharmaceutical industries, endangering the health of the popular strata, is confirmed by the European Commission in its answer to a question of the European Parliamentary Group of the KKE regarding the gigantic proportions of up to 450% increases by the government of the ND in the prices of medicines” notes the EO of the KKE and adds:
“The responsible Commissioner S. Kyriakidou specifically mentions in her answer that “the pharmaceutical strategy for Europe and the reform of the EU pharmaceutical legislation aim to balance various main objectives, including access to medicines, the competitiveness of the EU pharmaceutical sector, as well and the affordability of medicines for both patients and healthcare systems”.
In other words, the harmful perception of medicine as a commodity that is under the grip of the profitability and competitiveness of the pharmaceutical industry and which not only does not ensure “affordable medicine”, but on the contrary raises prices, depriving the people more and more of it, is confirmed, which is harmful to the people.
The response also states that “the Commission’s reform proposal aims to facilitate the timely entry of generic and biosimilar medicines to improve the affordability of medicines…” when a few months ago the Greek government increased the participation of insured persons in the supply of generic medicines .
It is also provocative the ball of responsibility that the Commission puts forward for the health sector citing “national competence” since the direction of reducing the budget for the health sector is clear both from the governments and from the EU guidelines that promote a reduction of the budget for health by redirecting funds to the “war economy”.
The excruciating increases in drug prices for patients are also in absolute consequence and continuation of the strategy of all governments in Health and the cuts in their budgets. The only beneficiaries of the increases are the pharmaceutical manufacturers, who after all asked for them, and not the thousands of patients who are faced with the well-known extortionate dilemma of price increases or drug shortages and experience the consequences of the policy that treats medicine as a commodity.”
“That is why now it is necessary to strengthen the fight for complete and absolutely free pharmaceutical care for the people, for the abolition of all participation-payment of all patients for all medicines, for their full compensation from the EOPYY, with 100% financing from the state budget and taxation of capital” underlines the conclusion of the EO of the KKE.
Read also:
PASOK: Changes and redistribution of roles are being prepared – Androulakis met with Diamantopoulou
SYRIZA: Oxymoron for the representative of the government of Bazoma to talk about disinformation
“Nails” Bakoyannis to Samaras: “We tried the most right-wing rhetoric and got 18%, it’s better not to try again” (Video)
!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,’script’,
‘
fbq(‘init’, ‘726515947549353’);
fbq(‘track’, ‘PageView’);
#KKE #Commissions #response #outrageous #increases #drug #prices #mockery
